InMed Pharmaceuticals Inc. (INM)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Mar. 26, 2026 | CORRESP | Neutral/Informational | Moderate | InMed Pharmaceuticals Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3, which was filed on March 20, 2… | Read Filing EDGAR |
| Mar. 25, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to InMed Pharmaceuticals Inc. that they will not review the company's registration statement filed on March 20, 2026. The letter emphasizes that the respo… | Read Filing EDGAR |
| Jul. 31, 2025 | CORRESP | Neutral/Informational | Moderate | InMed Pharmaceuticals Inc. has submitted a correspondence to the SEC to withdraw its previous request for the acceleration of its Registration Statement on Form S-1, originally fi… | Read Filing EDGAR |
| Jul. 14, 2025 | CORRESP | Neutral/Informational | Moderate | InMed Pharmaceuticals Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1, which was filed on July 9, 20… | Read Filing EDGAR |
| Jul. 14, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated July 14, 2025, informs Eric Adams, CEO of InMed Pharmaceuticals Inc., that the agency has not reviewed and will not review the company's registration … | Read Filing EDGAR |